Development of cutaneous squamous cell carcinoma during pembrolizumab therapy

J Dermatol. 2021 Jan;48(1):e7-e8. doi: 10.1111/1346-8138.15614. Epub 2020 Sep 17.

Affiliations

¹ Departments of, Department of, Dermatology, Graduate School of Medicine, Mie University, Tsu, Japan.
² Department of, Clinical Laboratory, Graduate School of Medicine, Mie University, Tsu, Japan.
³ Department of, Pathology, Graduate School of Medicine, Mie University, Tsu, Japan.

PMID: 32940367
DOI: 10.1111/1346-8138.15614

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Carcinoma, Squamous Cell* / chemically induced
Carcinoma, Squamous Cell* / drug therapy
Humans
Skin Neoplasms* / chemically induced
Skin Neoplasms* / drug therapy
Squamous Cell Carcinoma of Head and Neck

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab